Zorecimeran

佐西米瑞

Report date: 2026/05/12 09:17:30

Base Information

Drug NameZorecimeran
Drug Alias NameSARS-CoV-2 Vaccine (CureVac)CVnCoV Vaccine (CureVac)CVnCoVCV-07050101
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus InfectionsSevere Acute Respiratory Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumPanamaNetherlands +[11] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesCurevac Ag
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline PlcCurevac Ag
Inactive CompaniesBayer AG
Active IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus InfectionsSevere Acute Respiratory Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A